HEATHER FREEMAN: Open Payments
NPI 1497261754 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 50 payments from 14 companies in 2025. Trend: 2023 $960 · 2024 $1,644 · 2025 $1,289
Food & beverage: $1,289
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $456 |
| ABBVIE INC. | 13 | $230 |
| Janssen Biotech, Inc. | 6 | $122 |
| Organon LLC | 5 | $103 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Lilly USA, LLC | 2 | $69 |
| Incyte Corporation | 3 | $56 |
| GENZYME CORPORATION | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| LEO Pharma Inc. | 1 | $29 |
Products named: OTEZLA, SKYRIZI, TREMFYA, VTAMA, DUPIXENT, TALTZ, OPZELURA, RINVOQ.
Industry payments across FL — which companies pay providers there.
